Company overview

Leading with purpose. Every day.“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.”Emil D. Kakkis, M.D., Ph.D.Chief Executive Officer and PresidentWe have an inclusive culture of value and respect.Ultragenyx brings novel products to those living with rare and ultrarare diseases with a focus on debilitating genetic diseases. Founded in 2010, we have rapidly built a diverse portfolio of approved therapies and products aimed at diseases with a high unmet medical need for which many have no approved therapies. It takes courage, care, talent, and dedication to make a meaningful impact for those living with rare diseases, their families and the rare disease community. We put our people first, so they can take care of the rare disease community.We purposefully cultivate and nurture a dynamic, supportive work environment where we encourage every team member to share their new ideas and help us unlock more possibilities. Our team is made up of exceptional and diverse people with a strong passion and commitment to helping those living with rare diseases. By embracing generosity, curiosity, inclusion, and humility we are constantly learning together—fostering an environment that supports profound growth and fulfillment.If you want to have a meaningful impact, do the best work of your career while having fun and growing professionally and personally, come join our team!Visit our community guidelines at: https://ultragenyx.co/community
Founded in 2010
Novato, California, USA
1.6K employees
74% recommend to a friend
73% positive business outlook

Salaries

Typical salary range

$187,100 – $231,200

/ yr

Help build salary transparency at Ultragenyx

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +6.2% year over year

Funding

Total funding

$1.5B

Last raise

$400M

Post IPO Debt, 4 months ago

Funding history

Nov 2025

Post IPO Debt Ultragenyx Pharmaceutical · $400M

Jun 2024

Post IPO Equity Ultragenyx Pharmaceutical · $350M

Oct 2023

Post IPO Equity Ultragenyx Pharmaceutical · $300M

Feb 2019

Post IPO Equity Ultragenyx Pharmaceutical · $304.3M

Jun 2016

Post IPO Equity Ultragenyx Pharmaceutical · $65M

Dec 2012

Series B Ultragenyx Pharmaceutical · $75M

Audience

Monthly website visitors
43.9K
Month over month-13.3%
Quarter over quarter-12.9%
Top sourceSearch (51.8%)
Ad budget per month$0.0
Average search rank52.6
Traffic source mix
Search
51.8%
Direct
37.8%
Referral
8.2%
Social
1.1%
Paid referral
0.9%

LinkedIn followers

Follower count and growth

Total followers

107.8K

12-mo growth

+22.5%

Monthly growth

+2.2%

News

Links